» Articles » PMID: 23807855

Medical Technology As a Key Driver of Rising Health Expenditure: Disentangling the Relationship

Overview
Publisher Dove Medical Press
Specialty Health Services
Date 2013 Jun 29
PMID 23807855
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Health care spending has risen steadily in most countries, becoming a concern for decision-makers worldwide. Commentators often point to new medical technology as the key driver for burgeoning expenditures. This paper critically appraises this conjecture, based on an analysis of the existing literature, with the aim of offering a more detailed and considered analysis of this relationship. Several databases were searched to identify relevant literature. Various categories of studies (eg, multivariate and cost-effectiveness analyses) were included to cover different perspectives, methodological approaches, and issues regarding the link between medical technology and costs. Selected articles were reviewed and relevant information was extracted into a standardized template and analyzed for key cross-cutting themes, ie, impact of technology on costs, factors influencing this relationship, and methodological challenges in measuring such linkages. A total of 86 studies were reviewed. The analysis suggests that the relationship between medical technology and spending is complex and often conflicting. Findings were frequently contingent on varying factors, such as the availability of other interventions, patient population, and the methodological approach employed. Moreover, the impact of technology on costs differed across technologies, in that some (eg, cancer drugs, invasive medical devices) had significant financial implications, while others were cost-neutral or cost-saving. In light of these issues, we argue that decision-makers and other commentators should extend their focus beyond costs solely to include consideration of whether medical technology results in better value in health care and broader socioeconomic benefits.

Citing Articles

HTA Reshaping: Rethinking the Health Technology Assessment Framework in Portugal.

Pereira J, Alves J, Rodrigues B, Caetano R, Brito-Cruz P, Sousa J Port J Public Health. 2024; 39(1):36-47.

PMID: 39469038 PMC: 11320070. DOI: 10.1159/000516501.


Mapping the research of nursing in Parkinson's disease: a bibliometric and quantitative analysis.

Liao H, Fang Y, Chen S, Yin Y, Li J, Zhou P Front Neurol. 2024; 15:1412158.

PMID: 39385816 PMC: 11461253. DOI: 10.3389/fneur.2024.1412158.


Consequences of Information and Communication Technologies and Environmental Degradation on Health Expenditure.

Bayraktar Y, Aydin S, Cakir M, Recepoglu M, Ozyilmaz A, Buyukakin F Inquiry. 2024; 61:469580241277449.

PMID: 39373159 PMC: 11459522. DOI: 10.1177/00469580241277449.


Recent advances of 3D-printing in spine surgery.

Iqbal J, Zafar Z, Skandalakis G, Kuruba V, Madan S, Kazim S Surg Neurol Int. 2024; 15:297.

PMID: 39246777 PMC: 11380890. DOI: 10.25259/SNI_460_2024.


The hospital at home in the USA: current status and future prospects.

Pandit J, Pawelek J, Leff B, Topol E NPJ Digit Med. 2024; 7(1):48.

PMID: 38413704 PMC: 10899639. DOI: 10.1038/s41746-024-01040-9.


References
1.
Sharples L, Dyer M, Cafferty F, Demiris N, Freeman C, Banner N . Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK). J Heart Lung Transplant. 2006; 25(11):1336-43. DOI: 10.1016/j.healun.2006.09.011. View

2.
Packer C, Simpson S, Stevens A . International diffusion of new health technologies: a ten-country analysis of six health technologies. Int J Technol Assess Health Care. 2006; 22(4):419-28. DOI: 10.1017/S0266462306051336. View

3.
Koenig L, Siegel J, Dobson A, Hearle K, Ho S, Rudowitz R . Drivers of healthcare expenditures associated with physician services. Am J Manag Care. 2003; 9 Spec No 1:SP34-42. View

4.
Cohen D, Murphy S, Baim D, Lavelle T, Berezin R, Cutlip D . Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J Am Coll Cardiol. 2004; 44(9):1801-8. DOI: 10.1016/j.jacc.2004.05.086. View

5.
Yock C, Boothroyd D, Owens D, Garber A, Hlatky M . Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med. 2003; 115(5):382-9. DOI: 10.1016/s0002-9343(03)00296-1. View